Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- The Notion of Epigenetics
-
1. Cytoplasmic epigenetics: inheritance by cytoplasmic continuity
- Prof. Philippe Silar
- Dr. Fabienne Malagnac
- Epigenetics: Paradigms
-
2. The molecular mechanism of X chromosome inactivation
- Prof. Neil Brockdorff
-
3. Genomic imprinting: history and embryology
- Prof. Davor Solter
-
4. X chromosome inactivation in human cells
- Prof. Barbara Migeon
-
5. RNAi and heterochromatin in plants and fission yeast
- Prof. Robert Martienssen
- Epigenetics: Mechanisms
-
6. Polycomb epigenetic mechanisms: role of PcG complexes
- Prof. Vincenzo Pirrotta
-
7. Polycomb epigenetic mechanisms: methylation of DNA
- Prof. Vincenzo Pirrotta
-
8. Histone modifications and prospects for an epigenetic code
- Prof. Bryan Turner
-
9. Epigenetic control by histone methylation
- Prof. Thomas Jenuwein
-
10. Histone dynamics, heritability and variants
- Dr. Genevieve Almouzni
-
11. Gene silencing in budding yeast
- Prof. Susan Gasser
- Epigenetics: Heritability and Reversibility
-
12. Nuclear cloning, stem cells and epigenetic reprogramming
- Prof. Rudolf Jaenisch
-
13. Stem cell memory
- Prof. James Sherley
- Archived Lectures *These may not cover the latest advances in the field
-
14. Epigenetics: a historical overview
- Dr. Robin Holliday
-
15. DNA methylation
- Prof. Adrian Bird
-
16. DNA methylation and genome defense in Neurospora crassa
- Prof. Eric Selker
-
18. Evolution of mammal epigenetic control systems
- Prof. Jenny Graves
-
19. Genomic imprinting and its regulation
- Dr. Anne Ferguson-Smith
-
20. Nuclear organization and gene expression
- Prof. David Spector
-
21. Germ cells
- Prof. Azim Surani
-
22. Epigenetic regulation of phenotype
- Prof. Emma Whitelaw
-
24. Cytoplasmic epigenetics: proteins acting as genes
- Prof. Reed Wickner
Printable Handouts
Navigable Slide Index
- Epigenetically mediated gene silencing
- Process of DNA methylation
- Altered chromatin status in cancer
- Familial cancer genes
- Chromatin composition
- Screening the cancer genome
- Vogalstein paradigm
- Re-activated hypermethylated genes
- Hypothesis-early stage epigenetic gene silencing
- Epigenetic & genetic interaction in tumorigenesis
- sFRP genes - what are they?
- SFRP hypermethylation and CRC progression
- Epigenetic silencing of SFRPs in CRC
- Concept of cancer pathway addiction
- Collaboration in early colon tumorigenesis
- Heretical hypothesis
- Re-activated hypermethylated genes
- Screening the cancer genome
- HIC-1 is a candidate tumor suppressor gene
- HIC-1 hypermethylation in human cancer
- Targeted disruption of mouse Hic-1 gene
- Hic-1 as a tumor suppressor in mouse models
- Epigenetic and genetic interactions
- The full activities if HIC-1
- Properties of SIRT1
- Paradigm summary for HIC-1 P53 interaction
- Hypothesis review
- Translational implications
Topics Covered
- Introduction to epigenetic changes in cancer
- defining the process of promoter DNA hypermethylation as a constituent of a broad range of chromatin abnormalities in cancer
- defining the genes aberrantly silenced in cancer including approaches being used to screen the cancer genome for such genes
- defining what is known about the interaction of DNA methylation and chromatin modifications for initiating and maintaining gene silencing in cancer
- outlining the position of aberrant gene silencing in tumor progression and particularly highlighting the key role these changes may play for the earliest steps in tumorigenesis
- defining the potential for using DNA hypermethylated gene promoter sequences as molecular markers for cancer risk assessment, early diagnosis and prognosis
- discussing the possibilities for targeting reversal of gene silencing as a prevention and therapeutic strategy for cancer
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Baylin, S. (2007, October 1). Epigenetically mediated gene silencing: a companion to genetic alterations in driving tumorigenesis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/VRTX2257.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Stephen Baylin has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Epigenetically mediated gene silencing: a companion to genetic alterations in driving tumorigenesis
A selection of talks on Cancer
Hide